SAN DIEGO--(BUSINESS WIRE)--June 5, 2006--PrecisionMed, Inc. and Dx INNOVATIONS, Inc. are pleased to announce the results of a collaborative effort that enabled novel diagnostic procedures based on extracellular nucleic acids identified in cerebrospinal fluid.
